产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
名称 | HCCC-9810 (人胆管细胞型肝癌细胞) (STR鉴定正确) |
别称 | HCCC9810; Hccc9810 |
种属 | 人 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2-3次/周 |
背景描述 | HCCC-9810细胞源自一位女性肝胆管细胞癌患者,呈上皮细胞样。HCCC-9810细胞染色体模式数为71,但其染色体数目可以在22-117的范围内变动。HCCC-9810细胞倍增时间为20.4小时;细胞内AFP、CEA和CA19-9的分泌水平低,HCCC-9810细胞在裸鼠中的成瘤率为20%。 |
年龄(性别) | 女性 |
组织来源 | 肝胆管细胞癌 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肝胆癌细胞 |
致瘤性 | Yes, in nude mice. |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 11,12 D2S1338 17,19 D3S1358 17 D5S818 11 D7S820 10,12 D8S1179 10,13 D13S317 11 D16S539 9,12 D18S51 15 D19S433 13,14 D21S11 30,32 FGA 23,24 PentaD 9,13 PentaE 19 TH01 9 TPOX 8,11 vWA 16,17 D6S1043 19 D12S391 19 D2S441 12 -
STR鉴定图
参考文献
-
The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations(2024/01/11)
作者:Yangyang Feng, Ming Zhao, Lijian Wang
期刊:Cell Death & Disease
DOI:10.1038/s41419-023-06406-7
影响因子 :9.000
引用产品:CL-0095
-
Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma(2023/09/16)
作者:Bing Zhu, Xinyan Wang, Takaya Shimura
期刊:npj Precision Oncology
DOI:10.1038/s41698-023-00447-z
影响因子 :7.900
-
METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10(2022/12/07)
作者:Jingli Cai, Zheng Cui, Jingyi Zhou
期刊:Cancer Cell International
DOI:10.1186/s12935-022-02809-2
影响因子 :5.800
-
Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma(2020/11/10)
作者:Xiangyu Zhai, Wei Wang, Yunlong Ma
期刊:Aging-US
影响因子 :5.200
-
Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma(2023/06/05)
作者:Wei Zhao, Jing Zhao, Kun Li
期刊:LABORATORY INVESTIGATION
DOI:10.1016/j.labinv.2023.100193
影响因子 :5.000
-
Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis(2024/02/28)
作者:Chao Zhang, Chengkun Qin
期刊:Human Cell
DOI:10.1007/s13577-024-01032-7
影响因子 :4.300
引用产品:CL-0095
-
Curcumol Exerts Anticancer Effect in Cholangiocarcinoma Cells via Down-Regulating CDKL3(2018/3/20)
作者:Jinduo Zhang, Gang Su, Zengwei Tang
期刊:Frontiers in Physiology
影响因子 :4.000
引用产品:CL-0095
-
Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin(2018/05/25)
作者:Qixiang Ma, Yanyan Feng, Kaiwen Deng
期刊:Journal of Cancer
影响因子 :3.900
-
LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis(2021/2/8)
作者:Wei Zhao, Jing Zhao, Xiao Guo
期刊:Bmc Cancer
DOI:10.1186/s12885-021-07838-0
影响因子 :3.800
-
Guanine nucleotide exchange factor T exerts the cancer-promoting function in cholangiocarcinoma by enhancing the Wnt-GSK-3β-β-catenin cascade via regulation of Rac1/Cdc42(2023/03/26)
作者:Xifang Wang, Xiaomin Zhang, Jingying Sun
期刊:TOXICOLOGY AND APPLIED PHARMACOLOGY
DOI:10.1016/j.taap.2023.116492
影响因子 :3.800
-
Repression of LSD1/KDM1A activity improves the response of liver cancer cells to the lenvatinib(2024/03/28)
作者:Yi Zong, Zhigang Tao, Siyi Jiang
期刊:Discover Oncology
DOI:10.1007/s12672-024-00947-9
影响因子 :2.200
引用产品:CL-0095
-
7-Methoxy-13-dehydroxypaxilline: New indole diterpenoid from an endophytic fungus Penicillium sp. Nb 19(2022/08/05)
作者:Jing Yu, Jiapeng Wang, Shifang Liu
期刊:NATURAL PRODUCT RESEARCH
DOI:10.1080/14786419.2022.2107639
影响因子 :2.200
-
Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression.(2022/11/04)
作者:Sun J, Feng M, Zou H, Mao Y, Yu W
期刊:HISTOLOGY AND HISTOPATHOLOGY
影响因子 :2.000
FAQs
Q:{{item.question}}
A:{{item.answer}}
产品资料
识别码示意图